Susquehanna International Group
TNDM icon

Susquehanna International Group’s Tandem Diabetes Care TNDM Stock Holding History

Susquehanna International Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.99M Sell
104,000
-13,500
-11% -$293K ﹤0.01% 6187
2025
Q4 		$2.58M Buy
117,500
+92,900
+378% +$1.68M ﹤0.01% 5147
2025
Q3 		$299K Sell
24,600
-900
-4% -$12.2K ﹤0.01% 10118
2025
Q2 		$475K Sell
25,500
-95,800
-79% -$1.9M ﹤0.01% 9292
2025
Q1 		$2.32M Buy
121,300
+11,400
+10% +$334K ﹤0.01% 5191
2024
Q4 		$3.96M Buy
109,900
+19,800
+22% +$670K ﹤0.01% 3967
2024
Q3 		$3.82M Sell
90,100
-41,000
-31% -$1.74M ﹤0.01% 4091
2024
Q2 		$5.28M Sell
131,100
-179,800
-58% -$7.5M ﹤0.01% 3350
2024
Q1 		$11M Buy
310,900
+225,600
+264% +$6.04M ﹤0.01% 2472
2023
Q4 		$2.52M Sell
85,300
-41,300
-33% -$857K ﹤0.01% 4887
2023
Q3 		$2.63M Buy
126,600
+78,300
+162% +$2.15M ﹤0.01% 4621
2023
Q2 		$1.19M Buy
48,300
+13,100
+37% +$421K ﹤0.01% 6292
2023
Q1 		$1.43M Buy
35,200
+4,300
+14% +$178K ﹤0.01% 5913
2022
Q4 		$1.39M Sell
30,900
-64,200
-68% -$2.91M ﹤0.01% 5462
2022
Q3 		$4.55M Sell
95,100
-61,500
-39% -$3.37M ﹤0.01% 3311
2022
Q2 		$9.27M Buy
156,600
+17,200
+12% +$1.41M ﹤0.01% 2299
2022
Q1 		$16.2M Sell
139,400
-126,800
-48% -$14.8M ﹤0.01% 1935
2021
Q4 		$40.1M Sell
266,200
-14,400
-5% -$1.94M 0.01% 1261
2021
Q3 		$33.5M Sell
280,600
-70,500
-20% -$7.77M ﹤0.01% 1479
2021
Q2 		$34.2M Buy
351,100
+115,000
+49% +$10.3M ﹤0.01% 1488
2021
Q1 		$20.8M Buy
236,100
+37,700
+19% +$3.5M ﹤0.01% 1817
2020
Q4 		$19M Sell
198,400
-154,100
-44% -$15.9M ﹤0.01% 1798
2020
Q3 		$40M Buy
352,500
+83,000
+31% +$8.72M 0.01% 992
2020
Q2 		$26.7M Buy
269,500
+35,500
+15% +$2.83M 0.01% 1198
2020
Q1 		$15.1M Buy
234,000
+60,500
+35% +$4.24M ﹤0.01% 1386
2019
Q4 		$10.3M Sell
173,500
-34,900
-17% -$2.15M ﹤0.01% 2053
2019
Q3 		$12.3M Sell
208,400
-220,400
-51% -$14.1M ﹤0.01% 1765
2019
Q2 		$27.7M Sell
428,800
-98,000
-19% -$6.32M 0.01% 1065
2019
Q1 		$33.5M Buy
526,800
+186,300
+55% +$9.79M 0.01% 859
2018
Q4 		$12.9M Sell
340,500
-430,800
-56% -$15.2M 0.01% 1389
2018
Q3 		$33M Buy
771,300
+439,600
+133% +$15.4M 0.01% 941
2018
Q2 		$7.3M Buy
+331,700
New +$4.08M ﹤0.01% 2283
2016
Q1 		– Sell
-1,960
Closed -$231K – 9672
2015
Q4 		$231K Buy
+1,960
New +$194K ﹤0.01% 8183

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's TNDM Position: Q1 2026 in Review

Susquehanna International Group reduced its Tandem Diabetes Care (TNDM) stake by 38% in Q1 2026, selling an estimated $1.08M and leaving 80,749 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #6795.

Susquehanna International Group first reported a position in TNDM in Q2 2014 and has held it in 33 quarters since. The position peaked at $19.4M in Q3 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Susquehanna International Group held 80,749 shares of Tandem Diabetes Care worth $1.55M as of Q1 2026.
  • Susquehanna International Group sold 49,572 Tandem Diabetes Care shares in Q1 2026, an estimated $1.08M.
  • Tandem Diabetes Care made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6795 holding.
  • Susquehanna International Group first reported a position in Tandem Diabetes Care in Q2 2014 and has held it in 33 quarters since.
  • Susquehanna International Group's Tandem Diabetes Care position peaked at $19.4M in Q3 2020.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.